Mucus is a normal slippery secretion produced by our bodies to help protect against infections. The average human body produces about 2 litres a day.1
In the mucous lining of the nose, these secretions help to trap dust and pollution and other allergens – things which might trigger an allergic reaction, as well as bacteria and viruses. Mucus also helps to moisten the air we breathe and to prevent tissues in the airways from drying out.1
Mucus in the lungs, also known as phlegm, also helps to protect the delicate tissues from infection and from drying out. When we spit or cough up mucus, it is known as sputum.1
But sometimes we secrete more than usual, and if we have an infection or a condition such as asthma, COPD or cystic fibrosis, excess mucus production can cause its own problems.2
Please take a few moments to answer the following question, to help us learn more about your experience of Mucus Management
About the poll
Thank you for participating in this poll. Session control functionality Is included to prevent you from being able to answer questions more than once. The results are completely anonymous and will not be shared with any third parties. Teva UK Limited will use the results of this poll for market research, marketing purposes and to improve the site. (Job code:MUC/10/015h.Date of preparation: May 2012)
Richardson M. The physiology of mucus and sputum production in the respiratory system. Nursing Times 2003;99:63
Thornton DJ, et al. Structure and function of the polymeric mucins in airways mucus. Annual review of Physiology 2008;70:459-486
SIGN/BTS British Guideline
on the management of asthma http://www.sign.ac.uk/guidelines/
fulltext/101/index.html
Voynow JA, Rubin BK.
Mucins, mucus and sputum.
Chest 2009;135:505-12
Clinical Knowledge Summaries.
Patient information leaflet –
Lung cancer.
http://www.cks.nhs.uk/patient_
information_leaflet/lung_cancer
Cancer Research UK.
Lung cancer radiotherapy side effects. http://www.cancerhelp.org.uk/type/
lung-cancer/treatment/radiotherapy/
lung-cancer-radiotherapy-side-effects
NHS Choices.
Chest infection, adult – symptoms.
Available at
www.nhs.uk/Conditions/Chest-infection-adult/Pages/Symptoms.aspx
NICE. National Clinical Guideline Centre.
(2010) Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: National Clinical Guideline Centre.
Available from: http://guidance.nice.org.uk/CG101/
Guidance/pdf/English
Poole P, Black PN.
Mucolytic agents for chronic bronchitis
or chronic obstructive pulmonary
disease (Review).
The Cochrane Library 2010; 2: 1-66
Clinical Knowledge Summaries.
Patient information leaflet - Cystic fibrosis.
Available at
www.cks.nhs.uk/patient_information_
leaflet/cystic_fibrosis/symptoms
Logan JL.
The TG system for bedside recording
of sputum colour.
Ulster Med J 2006;75:228-30
Clinical Knowledge Summaries.
Palliative cancer care – cough.
www.cks.nhs.uk
Cystic Fibrosis Trust.
Clinical guidelines for the physiotherapy management of cystic fibrosis. 2002.
Available from:
www.cftrust.org.uk
Thank you for participating in this poll. Session control functionality Is included to prevent you from being able to answer questions more than once. The results are completely anonymous and will not be shared with any third parties. Teva UK Limited will use the results of this poll for market research, marketing purposes and to improve the site.